IMPORTANCE Skin cancer screening may improve melanoma outcomes and keratinocyte carcinoma morbidity, but little is known about the feasibility of skin cancer training and clinical skin examination (CSE) by primary care practitioners (PCPs) in large health care systems.
S ome evidence suggests that skin cancer screening through clinical skin examination (CSE) may reduce melanoma-associated mortality. 1 Despite the potential value of screening, the US Preventive Services Task Force concluded in 2016 that there was insufficient worldwide evidence to recommend for or against skin cancer screening by primary care practitioners (PCPs), highlighting the need to delineate the potential associated harms. 2 Melanoma incidence and associated mortality rates continue to increase in white men 50 years and older, 3 who comprise most patients in the Veterans Affairs (VA) Health Care System (HCS). 4 This at-risk population makes a mean of 3.6 primary care visits each year, 5 and the integrated nature of the VA HCS presents an ideal setting in which to assess the practicality of PCP skin screening.
We conducted a pilot study in the VA Palo Alto HCS to (1) determine the feasibility of skin cancer training of PCPs using the validated Internet Curriculum for Melanoma Early Detection (INFORMED) training module 6 and (2) compare preintervention vs postintervention dermatology referrals, skin biopsies, and PCP diagnostic accuracy.
Methods
Six PCPs volunteered to complete the 1.5-hour, web-based INFORMED training for skin cancer detection (excluding dermoscopy) and to conduct skin screening. The modified INFORMED was made available on May 1, 2015. More than 650 patients 35 years or older who were scheduled for an annual health habits screen visit with a participating PCP were mailed a research consent letter 1 month before the visit. Screening occurred from June 18, 2015, through August 30, 2016 (postintervention period). The PCPs completed a brief template in the electronic health record to verify CSE performance, examination type, presumptive skin cancer or precancer diagnosis, and referral to a dermatologist. Demographic and clinical information was recorded at the time of screening, along with dermatologic assessment of referred patients through October 31, 2016. The study was approved by the Stanford University Institutional Review Board and VA Palo Alto HCS Research Administration. Dermatologists were masked regarding prior PCP screening. Diagnostic accuracy was defined as a correct PCP presumptive diagnosis of skin cancer (melanoma, basal cell carcinoma, or squamous cell carcinoma) or actinic keratosis (AK) compared with diagnosis by the dermatologist; cases of AK were included because they were part of INFORMED training and allowed dermatology consultation. Skin cancer was histologically confirmed; AK was clinically diagnosed.
The proportion of dermatology referrals and skin biopsies from all outpatient visits of patients 35 years or older was compared among the 5 key participating PCPs 14 months before the intervention (February 18, 2014, through April 30, 2015) and after the intervention. Semistructured interviews of 2 PCPs (who screened and referred >64.5% of patients) were conducted after study completion to assess their perception of the education and screening process. Means (SDs) or medians (ranges) were reported in univariate analyses. Bivariate comparisons were performed with χ 2 tests or Fisher exact tests for categorical variables and Wilcoxon rank sum test for continuous variables. All tests were 2-sided with P < .05 considered to be statistically significant. Statistical analyses were conducted using SAS statistical software, version 9.4 (SAS Institute Inc). Overall, 62 of 189 patients (32.8%) were referred to a dermatologist: 33 (53.2%) for presumptive skin cancer and 15 (24.2%) for AK; 12 (6.3%) failed to schedule a follow-up. Fourteen skin biopsies were performed in the dermatology clinic to exclude melanoma or KC in 9 of the 189 patients (4.7%), 4 of whom had melanoma in situ, basal cell carcinoma, and/or squamous cell carcinoma (Figure) . Correct diagnoses were made by PCPs in 13 of 38 patients (34.2%; 4 of 27 patients [14.8%] diagnosed with skin cancer and 5 of 11 patients [45.5%] diagnosed with AK). Of the 23 screened patients with false-positive results who were incorrectly referred for presumptive skin cancer, 10 were diagnosed with seborrheic keratosis, 5 with AK, and 8 with other skin issues ( Table 1) .
Results

Six
Comparison of all outpatient visits for the 5 main participating PCPs before vs after intervention revealed no significant differences in dermatology referrals overall and for presumptive skin cancer or AK, skin biopsies, or PCP diagnostic accuracy with the exception of significantly fewer postintervention dermatology referrals that lacked specific diagnoses (25 [1.0%] vs 10 [0.4%], P = .01) ( Table 2) .
Review of PCP physical examination findings after intervention revealed a higher quality of CSE documentation. The
Key Points
Question Do dermatology referral patterns and skin biopsies differ after skin cancer education and screening by primary care practitioners in a Veterans Affairs Health Care System? Findings In this pilot intervention study of 258 patients offered screening, the overall diagnostic accuracy was 34.2% for skin cancer and precancer, 14.8% for skin cancer, and 45.5% for precancer. No significant differences were observed in this measure or the proportion of referrals and skin biopsies before vs after intervention, although the quality of dermatology referrals improved after training.
Meaning Additional studies are needed to determine whether primary care-based screening can be implemented without a substantial burden on large health care systems. top 2 screening and referring PCPs reported greater confidence that the training had improved their ability to correctly identify skin lesions and a higher degree of accuracy about making the decision whether to refer. Routine screening was not sustained as a part of their practice 5 months after study completion because of the time required for patients to undress for CSE and competing medical conditions of higher priority.
Discussion
Our pilot study found similar rates of dermatology referrals and skin biopsies after PCP INFORMED training and screening compared with the preintervention period, suggesting feasibility and need for further study across the VA HCS. The ability to perform and document CSE showed marked improvement after training, with more precise terms used and increased notation of physician concern for benign vs malignant skin neoplasms. These findings were generally not recorded in the preintervention period, highlighting the difficulty of measuring change in screening-related outcomes even in a closed HCS with an integrated electronic health record system.
Since the 2016 US Preventive Services Task Force statement, 2 the first analysis of a PCP screening quality initiative in western Pennsylvania revealed no increase in the number of specialty referrals or surgical procedures, although individual-level data were not available to directly compare outcomes of screened patients. 7 Hospital record and cancer registry data subsequently collected on screened vs unscreened patients demonstrated that screened patients were more likely to be diagnosed with melanoma and have thinner tumors (mean Breslow thickness, 0.37 vs 0.65 mm; P < .001) and more melanomas in situ. 8 The changing nature in which primary care is delivered in large health care systems may impede widespread implementation of PCP skin screening.
9 Practitioners perform fewer comprehensive physical examinations and instead focus on counseling related to active medical conditions or disease prevention. 10 It is less time consuming for PCPs to forgo CSE and refer patients if dermatologist access is readily if the patient is already placed in a gown; improved patient education regarding skin self-examination and clinical warning signs could also play a role. Because nearly one-third of melanomas are located on the back in men, 11 the waist-up examination may be most time efficient and of greatest yield in this group at increased risk for fatal melanoma.
Limitations
Our pilot study was not powered to detect differences in melanoma stage or thickness at diagnosis and included both KCs and AK because of cost implications related to their treatment.
12,13
Conclusions
Our study suggests that primary care-based skin cancer screening is feasible and may be performed without substantial associated harms in a population at risk for advanced melanomas and KCs, although time constraints remain an obstacle for PCPs. Discovered by Marie and Pierre Curie, the radioactive element radium became one of the first wonder drugs. Known for its alluring luminescence, the benefits of radium were touted both commercially as an additive in toothpaste, cosmetics, and even tonic water, as well as medically. The first published reports of radium therapy in dermatology described radium-containing disks or tubes applied to basal cell carcinomas, squamous cell carcinomas, nevi, warts, keloids, vascular lesions, and lupus erythematosus. At the American Dermatological Association Annual meeting in 1923, an overview of radium therapy concluded that "the introduction of radiotherapeutic agents into dermatologic practice constitutes, perhaps, the most important addition to this field of medicine in many years." 1(p50) Physicians were, however, warned about radium's deleterious effects, which included "hyperaemia… deep and intractable ulceration, to be followed later by telangiectasia, pigmentary anomalies, atrophy or keratosis, and occasionally, by malignant change." 2(p1353) Forebodingly, "grave and even fatal symptoms may be set up in the bones and in the blood stream years after treatment." 2(p1353) But for thousands of young, female workers employed to paint watch dials with luminous radium paint, no such warnings were given. To maximize efficiency and precision, the "radium girls," as they were eventually known, were instructed to place their brushes in their mouth to create a tapered point-"lip, dip, paint"-a routine performed hundreds of times per day, 6 to 7 days a week, and for some, for many years. Over time, one by one, the women began to fall ill. Their symptoms included jaw necrosis, nonhealing ulcers and abscesses, spontaneous fractures of the limbs or spine, aplastic anemia, and bone sarcomas. Many experienced a violent and agonizing death. While their range of afflictions puzzled physicians, a common thread appeared. All had been dial painters at one point in their lives. 3 With executives at the radium corporations going to great lengths to deny and cover up the association between radium and the deaths of young, previously healthy women, 2 pivotal lawsuits by tenacious former employees would improve labor safety standards, establish workers' compensation laws, and lead to the formation of the Occupational Safety and Health Administration. Furthermore, their contributions to science proved to be invaluable in the fields of nuclear physics, environmental science, and radiation and occupational medicine. While radiodermatitis and radium dermatitis were listed as occupational dermatoses as late as 1952, they are no longer a concern today. As medicine continues to advance, it is important not to forget the extraordinary sacrifices made by people from all walks of life to improve the human condition.
